{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T20:17:30Z","timestamp":1760645850565},"reference-count":25,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Federal Office of Public Health"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Drug Policy"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.drugpo.2011.05.015","type":"journal-article","created":{"date-parts":[[2011,6,28]],"date-time":"2011-06-28T13:33:46Z","timestamp":1309268026000},"page":"33-36","source":"Crossref","is-referenced-by-count":12,"title":["A high proportion of users of low-threshold facilities with needle exchange programmes in Switzerland are currently on methadone treatment: Implications for new approaches in harm reduction and care"],"prefix":"10.1016","volume":"23","author":[{"given":"Jean-Pierre","family":"Gervasoni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hugues","family":"Balthasar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Th\u00e9r\u00e8se","family":"Huissoud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9","family":"Jeannin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7oise","family":"Dubois-Arber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugpo.2011.05.015_bib0005","first-page":"804","article-title":"Evolution de la consommation et des pratiques \u00e0 risques de transmission du VIH et du VHC chez les consommateurs de drogue par injection en Suisse, 1993\u20132006","volume":"45","author":"Balthasar","year":"2007","journal-title":"Bulletin de l\u2019Office F\u00e9d\u00e9ral de la Sant\u00e9 Publique"},{"key":"10.1016\/j.drugpo.2011.05.015_bib0010","series-title":"Sant\u00e9, m\u00e9decine et soci\u00e9t\u00e9: contributions \u00e0 la sociologie de la sant\u00e9","first-page":"315","article-title":"Prise en charge de la toxicod\u00e9pendance en Suisse: une typologie des offres d\u2019aide \u00e0 \u2018bas seuil\u2019 et \u00e0 \u2018haut seuil\u2019","author":"Benninghoff","year":"1999"},{"issue":"4","key":"10.1016\/j.drugpo.2011.05.015_bib0015","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1080\/09540120500429018","article-title":"Health trends among drug users attending needle exchange programmes in Switzerland (1994\u20132000)","volume":"18","author":"Benninghoff","year":"2006","journal-title":"AIDS Care: Psychological and Socio-Medical Aspects of AIDS\/HIV"},{"key":"10.1016\/j.drugpo.2011.05.015_bib0020","series-title":"Preventing HIV infection among injecting drug users in high-risk countries. An assessment of the evidence","author":"Committee on the Prevention of HIV Infection among Injecting Drug Users in High-risk Countries","year":"2006"},{"issue":"21","key":"10.1016\/j.drugpo.2011.05.015_bib0025","first-page":"1","article-title":"Trends in drug consumption and risk of transmission of HIV and hepatitis C virus among injecting drug users in Switzerland, 1993\u20132006","volume":"13","author":"Dubois-Arber","year":"2008","journal-title":"Euro Surveillance"},{"key":"10.1016\/j.drugpo.2011.05.015_bib0030","first-page":"277","article-title":"Un syst\u00e8me de surveillance de deuxi\u00e8me g\u00e9n\u00e9ration pour am\u00e9liorer la surveillance du VIH\/sida en Suisse","volume":"15","author":"Dubois-Arber","year":"2006","journal-title":"Bulletin de l\u2019Office F\u00e9d\u00e9ral de la Sant\u00e9 Publique"},{"issue":"3","key":"10.1016\/j.drugpo.2011.05.015_bib0035","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0740-5472(00)00104-5","article-title":"Reduced injection frequency and increased entry and retention in drug treatment associated with needle exchange participation in Seattle drug injectors","volume":"19","author":"Hagan","year":"2000","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.drugpo.2011.05.015_bib0040","series-title":"European report on drug consumption rooms","author":"Hedrich","year":"2004"},{"issue":"2","key":"10.1016\/j.drugpo.2011.05.015_bib0045","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/00126334-200302010-00017","article-title":"Readiness for cessation of drug use among recent attenders and nonattenders of a needle exchange program","volume":"32","author":"Henderson","year":"2003","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"issue":"1","key":"10.1016\/j.drugpo.2011.05.015_bib0050","first-page":"3","article-title":"Substitutionsbehandlungen in der Schweiz: Fortsetzung einer Erfolgsgeschichte","author":"Hosek","year":"2006","journal-title":"Suchtmagazin"},{"issue":"1","key":"10.1016\/j.drugpo.2011.05.015_bib0055","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/1468-2427.00296","article-title":"Drug policy-making in metropolitan areas: Urban conflicts and governance","volume":"25","author":"K\u00fcbler","year":"2001","journal-title":"International Journal of Urban and Regional Research"},{"key":"10.1016\/j.drugpo.2011.05.015_bib0060","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1159\/000070984","article-title":"Estimated trends in the prevalence of heroin addiction in Switzerland: A multiple-indicator approach","volume":"9","author":"Maag","year":"2003","journal-title":"European Addiction Research"},{"issue":"3","key":"10.1016\/j.drugpo.2011.05.015_bib0065","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1080\/02791072.2002.10399965","article-title":"Demystifying the injection drug user: Willingness to participate in traditional drug treatment services among participants in a needle exchange program","volume":"34","author":"Mac Master","year":"2002","journal-title":"Journal of Psychoactive Drugs"},{"issue":"14","key":"10.1016\/j.drugpo.2011.05.015_bib0070","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1081\/JA-120014088","article-title":"Drug treatment referrals and entry among participants of a needle exchange program","volume":"37","author":"Riley","year":"2002","journal-title":"Substance Use and Misuse"},{"issue":"3","key":"10.1016\/j.drugpo.2011.05.015_bib0075","article-title":"Was sagt uns die methadonstatistik \u00fcber die Entwicklung der letzten Jahre? Ein Vergleich zwischen ausgew\u00e4hlten Kantonen","author":"Schorr","year":"2007","journal-title":"Abh\u00e4ngigkeiten"},{"key":"10.1016\/j.drugpo.2011.05.015_bib0080","series-title":"Analyse der T\u00e4tigkeiten und Angebotsbereiche in Anlaufstellen","author":"Spreyermann","year":"2003"},{"key":"10.1016\/j.drugpo.2011.05.015_bib0085","series-title":"Substitution-assisted treatment in opioid dependence. Summary of the clinical recommendations for Substitution-assisted treatment (SAT) in opioid dependence issued by the SSAM (Swiss Society of Addiction Medicine) in 2007","author":"Swiss Society of Addiction Medicine","year":"2010"},{"key":"10.1016\/j.drugpo.2011.05.015_bib0090","first-page":"1","article-title":"Premi\u00e8re enqu\u00eate nationale sur les usagers des CAARUD","volume":"61","author":"Toufik","year":"2008","journal-title":"Tendances"},{"key":"10.1016\/j.drugpo.2011.05.015_bib0095","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1159\/000259046","article-title":"Harm reduction: The case of Switzerland","volume":"1","author":"Uchtenhagen","year":"1995","journal-title":"European Addiction Research"},{"issue":"4","key":"10.1016\/j.drugpo.2011.05.015_bib0100","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1046\/j.1360-0443.2001.9645978.x","article-title":"Unsafe injecting practices among attendees of syringe exchange programmes in France","volume":"96","author":"Valenciano","year":"2001","journal-title":"Addiction"},{"issue":"9","key":"10.1016\/j.drugpo.2011.05.015_bib0105","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1111\/j.1360-0443.2007.01912.x","article-title":"Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: Evidence from the Amsterdam Cohort Studies among drug users","volume":"102","author":"van den Berg","year":"2007","journal-title":"Addiction"},{"issue":"5","key":"10.1016\/j.drugpo.2011.05.015_bib0110","doi-asserted-by":"crossref","first-page":"770","DOI":"10.2105\/AJPH.2004.057828","article-title":"Service uptake and characteristics of injection drug users utilizing North America's first medically supervised safer injection facility","volume":"96","author":"Wood","year":"2006","journal-title":"American Journal of Public Health"},{"issue":"2","key":"10.1016\/j.drugpo.2011.05.015_bib0115","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.amepre.2005.04.011","article-title":"Do supervised injecting facilities attract higher-risk injection drug users?","volume":"29","author":"Wood","year":"2005","journal-title":"American Journal of Preventive Medicine"},{"issue":"11","key":"10.1016\/j.drugpo.2011.05.015_bib0120","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1503\/cmaj.060863","article-title":"Summary of findings from the evaluation of a pilot medically supervised safer injecting facility","volume":"175","author":"Wood","year":"2006","journal-title":"CMAJ: Canadian Medical Association Journal=Journal de l\u2019Association M\u00e9dicale Canadienne"},{"key":"10.1016\/j.drugpo.2011.05.015_bib0125","series-title":"Evaluation of the Confederation's measures to reduce drug-related problems: Fourth synthesis report 1999\u20132002","author":"Zobel","year":"2003"}],"container-title":["International Journal of Drug Policy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955395911000971?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955395911000971?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T15:22:03Z","timestamp":1543677723000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0955395911000971"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S0955395911000971"],"URL":"https:\/\/doi.org\/10.1016\/j.drugpo.2011.05.015","relation":{},"ISSN":["0955-3959"],"issn-type":[{"value":"0955-3959","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}